Hrt Financial LP Revolution Medicines, Inc. Transaction History

Hrt Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$26.56 - $33.55 $1.7 Million - $2.15 Million	64,053 New	64,053 $2.06 Million
Q4 2022 Feb 10, 2023	BUY	$17.68 - $25.53 $1.74 Million - $2.51 Million	98,186 New	98,186 $2.34 Million
Q2 2022 Aug 12, 2022	BUY	$14.54 - $27.17 $422,561 - $789,614	29,062 Added 44.45%	94,448 $1.84 Million
Q1 2022 May 16, 2022	BUY	$17.31 - $26.4 $643,135 - $980,865	37,154 Added 131.6%	65,386 $1.67 Million
Q4 2021 Feb 14, 2022	BUY	$24.35 - $33.7 $687,449 - $951,418	28,232 New	28,232 $710,000

266

161M

260K

620K

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.8B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.